Tuesday, March 8, 2016

Two Studies Strengthen Links Between the Zika Virus and Serious Birth Defects


Photo
Beijamin Santos, who was born with microcephaly, undergoing physical therapy in Joao Pessoa, Brazil.CreditAndre Penner/Associated Press
The Zika virus damages many fetuses carried by infected and symptomatic mothers, regardless of when in pregnancy the infection occurs, according to a small but frightening study released on Friday by Brazilian and American researchers.
In a separate report published on Friday, other scientists suggested a mechanism for the damage, showing in laboratory experiments that the virus targets and destroys fetal cells that eventually form the brain’s cortex.
The reports are far from conclusive, but the studies help shed light on a mysterious epidemic that has swept across more than two dozen countries in the Western Hemisphere, alarming citizens and unnerving public health officials.
In the first study, published in The New England Journal of Medicine, researchers found that 29 percent of women who had ultrasoundexaminations after testing positive for infection with the Zika virus had fetuses that suffered “grave outcomes.”
They included fetal death, tiny heads, shrunken placentas and nerve damage that suggested blindness.
Photo
Neural progenitor cells exposed to Zika virus. The virus is shown in green, and cells that have died are shown in red. CreditSarah C. Ogden/Johns Hopkins Medicine
“This is going to have a chilling effect,” said Dr. Anthony S. Fauci, the director of the National Institute of Allergy and Infectious Diseases. “Now there’s almost no doubt that Zika is the cause.”
The small size of the study, which looked at 88 women at one clinic in Rio de Janeiro, was a limitation, Dr. Fauci added. From such a small sample, it is impossible to be certain how often fetal damage may occur in a much larger population.
Still, the high percentage of fetuses damaged is “very concerning,” he said. “There will be other studies that I believe will corroborate this.”
Two fetuses died even though the mothers were infected relatively late in pregnancy, at 25 and 32 weeks — and even after earlier ultrasounds had shown the fetuses to be normal.
“We were just blown away by that,” said Dr. Karin Nielsen-Saines of the David Geffen Medical School at the University of California, Los Angeles, and one of the lead authors. “We weren’t expecting to find problems in all trimesters.”
Other fetuses whose mothers were infected late in pregnancy suffered brain calcifications or abnormally slow growth.
Doctors in Brazil had previously said that the worst damage appeared in fetuses whose mothers were infected in the first trimester.
Zika has been likened to rubella because both cause mild symptoms in adults but maim or kill fetuses, and the new report’s authors compared their findings to the devastating American rubella outbreak of 1964.
Continue reading the main story

Short Answers to Hard Questions About Zika Virus

Why scientists are worried about the growing epidemic and its effects on pregnant women, and advice on how to avoid the infection.
Back then, almost 80 percent of American women had survived childhood infections with rubella and were immune. Nonetheless, that outbreak, the last before a vaccine was invented, killed at least 2,100 children and caused 20,000 others to be born with disabilities, including severe intellectual disabilitiesblindness and deafness.
Virtually no women in the Western Hemisphere are now immune to Zika, so many more children could be affected, the authors said.
The disease is not expected to have the same consequences in the United States because it is spread primarily by mosquitoes that thrive in tropical regions, but there is mounting evidence that it is also spread by sex.
Other scientists echoed Dr. Fauci’s assessment that the new research strongly indicated that the Zika virus, and nothing else, is behind Brazil’s wave of fetal brain damage.
“It does not close the deal, but it’s a huge step forward,” said Dr. Ernesto T. A. Marques, who studies Zika in Brazil and at the University of Pittsburgh Graduate School of Public Health but was not involved in the new research.
The World Health Organization is awaiting results from a similar but much larger study involving 5,000 women, mostly from Colombia. They are not expected until May or June, when large numbers of the babies will come to term.
The Brazilian study, which is still in progress, followed 88 pregnant women who visited a fever clinic at the Oswaldo Cruz Foundation hospital in Rio de Janeiro, one of Brazil’s leading research hospitals, between September and February.
Every woman with a rash, the most characteristic symptom of infection, was tested for the Zika virus, and 72 were positive. The tests looked for the virus itself; they work only if done early in an infection, but are considered more accurate than later tests for antibodies.
Photo
Guo-li Ming, left, and Hongjun Song at Johns Hopkins in front of images from a high-powered microscope.CreditJohns Hopkins Medicine
Forty-two of the infected women agreed to have a series of ultrasound scans, as did all 16 uninfected women.
Of the remaining 30 infected women, two miscarried and 28 declined the scans, the study’s authors said.
“Some women who said no said the campus where the ultrasounds were done was too far away,” Dr. Nielsen-Saines said. “But we think it was also not wanting to know. There’s a tendency to be fatalistic, to say, ‘God willing, everything will be fine,’ or ‘I’ll deal with it when the baby is born.’ ”
The bleakness of the results was startling. Of the 42 infected women receiving regular ultrasounds, a dozen had babies who died in utero or suffered serious birth defects. Only eight of the babies carried by the 42 women have been born so far, but the ultrasound scans for them turned out to be accurate. None of 16 uninfected women had problems in their scans.
The new study does not answer an important question: whether Zika infections so mild that they produce no symptoms in the mother can damage a fetus.
Doctors say four out of five Zika victims have no symptoms. When they do, the most common are rash, joint painred eyes and headaches.
Still, although it was small, “this kind of study is the gold standard,” Dr. Fauci said.
In the second study, published in the journal Cell Stem Cell, researchers at Johns Hopkins and elsewhere cultured several types of cells present in early fetal development, including so-called cortical neural progenitor cells, which form the cortex, the outer brain layer responsible for many higher functions.
Continue reading the main story


Three days after they infected all the cells with the Zika virus, 90 percent of the progenitor cells were damaged: They were unable to divide normally and often died.
By comparison, the other two types of fetal cells were much less affected.
“The cell types responsible for forming the cortex are the target of the Zika virus,” said Hongjun Song, a neurologist at Johns Hopkins University School of Medicine and a senior author of the study.
Some experts cautioned that, because the experiment was conducted with laboratory-grown cells, the results might not apply to humans.
“It might be that the results wouldn’t be the same in a living system of actual cortical stem cells,” said Dr. Catherine Y. Spong, acting director of the National Institute of Child Health and Human Development.
Cultured cells may be more susceptible to infections, she added.
Sara Cherry, a microbiologist at the University of Pennsylvania, called the study “really important” but noted that the cells were infected with a Zika strain “quite distinct” from the one now infecting people in Latin America.
Dr. William B. Dobyns, a pediatric neurologist at Seattle Children’s Research Institute, called the work “highly significant.”
If the cells that should form the brain cortex grow too slowly, he said, “you get a small brain, but on top of that there’s cell death, which means whatever the size the brain is, it will shrink.” That reduction may lead to a conspicuous space between the skull and brain.
“This paper fits like a glove what I’m seeing,” said Dr. Dobyns, who has reviewed brain scans from Brazil. Those scans have shown gaps between severely shrunken brains and the inner skull, unusually smooth brain surfaces and other anomalies.
Dr. Guo-li Ming, a Johns Hopkins neurologist and a senior author of the study, said the scientists’ experimental model could be used to test drugs that could prevent brain damage in fetuses.
NYTimes article             NEJM article

Scientists still fail to record age and sex of lab mice

NATURE | NEWS
Text-mining analysis finds that studies fall short of best practice — despite guidelines introduced in 2010.

Article toolsThe largest-ever analysis of the quality of mouse studies reveals that as recently as 2014, only around 50% of research papers recorded both the sex and age of the animals used — key details needed for others to assess and reproduce the research1.

ref 1
The analysis, which used software to trawl through the text of more than 15,000 open-access papers published between 1994 and 2014, also reveals the preferences of different research fields. Cardiovascular research tends to use male mice, whereas research on infectious diseases such as HIV and tuberculosis favours female mice, for example.
The study is “the strongest evidence about sex and age bias through biomedical research to date”, say its authors.

Sex matters

Many researchers have pointed out that male and female mice — like men and women — can have different responses to drugs or different behaviours in laboratory experiments. One study last year, for instance, found2 that although inhibiting the function of immune cells called microglia helps to relieve pain in male mice, it doesn’t do so in female mice. The difference might explain why some clinical trials of pain drugs have failed.

CRISPR: gene editing is just the beginning

The real power of the biological tool lies in exploring how genomes work


Maria Sharapova Admits Taking Meldonium, Drug Newly Banned by Tennis

 
Continue reading the main storyVideo

Sharapova Admits to Failing Doping Test

Maria Sharapova said the International Tennis Federation had notified her that she tested positive for a banned substance at the Australian Open in January.
 By THE ASSOCIATED PRESS on Publish DateMarch 7, 2016. Photo by Kevork Djansezian/Getty Images.Watch in Times Video »
Maria Sharapova, a five-time Grand Slam champion and the world’s highest-paid female athlete, announced Monday that she had tested positive for the recently banned drug meldonium at the Australian Open.
The tennis antidoping program confirmed the positive test, which occurred Jan. 26, the day Sharapova lost to Serena Williams in the quarterfinals. Sharapova, who has not played since because of a forearm injury, will be suspended provisionally Saturday pending a ruling in the case.
The commercial fallout was swift. Nike, one of Sharapova’s longtime sponsors, announced in a statement that it was suspending its relationship with her “while the investigation continues.” Sharapova has her own clothing line with Nike, with whom she signed an eight-year extension in 2010 that could reportedly be worth up to $70 million.
Sharapova, a 28-year-old Russian who is one of the world’s most visible sports figures, is by far the most prominent athlete to be barred for meldonium, a drug originally developed in Latvia for heart patients that aids blood flow and is not approved for sale in the United States.
Full Article

Friday, March 4, 2016

Brain power

NATURE | EDITORIAL
As brain stimulation finds non-medical uses, now is the time to consider its implications.

Article tools

Mopic/Alamy
Where should we draw the line on cognitive enhancement?
It is a cautionary tale for twenty-first-century medicine. Late last year, neurosurgeons in the United States reported odd symptoms in three of their patients. Well into their sixties and seventies, these people complained of headaches, nausea, unstable balance, weak legs, low blood pressure and falling down. Chest X-rays revealed the problem. Two devices implanted into their chests — a pacemaker to help their failing hearts and a battery unit that powered electrodes buried deep inside their heads to control the signature tremors of Parkinson’s disease — had been placed too close together. One machine was interfering with the functioning of the other (M. Sharma et al. Basal Ganglia 6, 19–22; 2016).
From iron lungs and dialysis machines to implantable defibrillators, we are used to technology helping our bodies. Deep-brain stimulation — the electrodes and battery implanted in the patients’ heads — has been helping people with neurological and psychiatric disorders for more than a decade, but it requires quite a commitment. Brain surgery is expensive and not for everybody. The number of people who might benefit is very small given the overall burden posed by mental illness and related problems. This is one reason why there is a lot of interest in cheaper and easier types of brain stimulation, which apply electric current and magnetic fields to the outside of the head.
If these types of brain stimulation are found not to produce much of a difference, then it will not have been for a lack of effort. Academic journals are filling up with case reports and preliminary trials of the technologies to help people with depression, autism spectrum disorders, schizophrenia, obsessive–compulsive disorder, addiction, anxiety and many more cognitive problems. It is early days, but there are enough positive results to draw the attention of people who struggle with such issues or know someone who does. Some of these people want to try it on themselves or their children. An electrical brain stimulator is fairly simple to make, and even simpler to buy from one of the companies that are popping up to sell them online. Self-medication has never been so high-tech.
Many neuroscientists have raised the alarm over do-it-yourself (DIY) brain stimulation, pointing out that it can be unsafe in the short term and might have side effects in the long term. Some want regulation. But there is another, more fundamental, ethical issue that must be confronted. As we report in an Outlook article on page S6 — one of a series of pieces that discuss cognitive enhancement — the use of DIY brain stimulators is not confined to those for whom conventional medicine has failed. A small but growing number of people want to use the devices to improve their natural mental abilities. And in so doing, this community is piggy-backing on scientific studies that suggest that electric currents and magnetic fields could improve academic performance by boosting memory and attention, and perhaps even alter attitudes.
The use of medicines to enhance performance in sport is frowned on, and a clear line has been drawn between taking them to treat and taking them to cheat. Could a similar distinction be made for cognitive-enhancement techniques? Should it be? It’s too soon to answer some of these questions — scientists and doctors must first reach consensus on the effectiveness of the techniques — but it is not too soon to ask them.

Wednesday, March 2, 2016

Campaign Promises

"You're not going to have the drugs coming in, destroying your children. Your kids are going to look all over the place and they're not going to be able to find them."
-- Donald Trump
"I would also get rid of Obamacare. We're going to have something much better."
-- Donald Trump